SEQH Capital Research

SEQH Capital Research

DNN Quantitative Analysis

SEQH Capital Research's avatar
SEQH Capital Research
Oct 25, 2025
∙ Paid

Denison Mines – Tear-Sheet
Price Target: C$5.00 within 12-18 months | Current: US$2.81 | Implied uplift: 78%

  1. Intrinsic Value
    Wheeler River is one of the few uranium projects that can be valued with high confidence: the 2023 feasibility study delivers an after-tax NPV of C$1.56 billion (8% discount) for the Phoenix deposit alone. Denison’s 95% interest therefore embeds C$1.48 billion of attributable value. Adding the Gryphon deposit (C$0.82 billion on the same basis) lifts the core in-situ NAV to roughly C$2.3 billion, or C$3.25 per fully-diluted share before any balance-sheet items. Net cash and the 2.5 million lb physical uranium inventory add a further C$0.70 per share, giving an adjusted NAV of C$3.95. Athabasca ISR assets with permits in hand historically re-rate to 1.2-1.3× NAV; applying a 1.25× multiple produces a fair-value reference of just under C$5.00 – the price target we adopt.

  2. Why a Premium is Warranted
    Phoenix is not simply another undeveloped deposit. The average grade inside the high-grade domain is 46% U₃O₈, two orders of magnitude above most global operations. All-in sustaining cost is forecast at C$21.73/lb, placing the operation in the first quartile of the cost curve and yielding a 90% internal rate of return at the US$66/lb base-case price used in the study. At today’s spot price of ~US$80/lb the post-tax NPV rises by roughly C$430 million, adding C$0.60 per share. The initial capex envelope of C$420 million is unusually low for a 5.7 Mlb/y producer; the pay-back period is ten months, not years. Taken together these metrics justify a valuation premium versus conventional hard-rock projects still wrestling with feasibility trade-offs.

  3. Catalyst Pathway
    The stock’s next re-rating step is regulatory, not geological. Provincial environmental approval was granted in July 2025; the Canadian Nuclear Safety Commission has scheduled public hearings for October and December 2025, with a final licence decision expected before year-end. A positive ruling removes the last material permitting risk and allows a construction decision in H1 2026. First uranium from the Phoenix ISR well-field is scheduled for H1 2028, at which point Denison transitions from developer to cash-flow generative producer. Each milestone—federal permit, FID, construction start—has historically moved North-American uranium names 15-25% on the day and drifted them higher into production.

  4. Macro Tailwind
    The uranium market is moving from cyclical recovery to structural deficit. Global reactor requirements are projected to grow 28% by 2030 yet mine supply is 25 million lb short of annual demand already. Long-term contracting by utilities has been largely absent since 2018; uncovered demand over the next five years exceeds 200 million lb. Spot uranium has re-entered the US$80s for the first time since 2011, and forward curves imply US$90-100/lb by mid-2026. Every US$10/lb move adds approximately C$0.90 to Denison’s NAV per share, providing visible leverage without operational risk.

  5. Balance-Sheet Optionality
    An upsized US$300 million convertible note (3.5%, conversion C$4.50) completed in August 2025 leaves the treasury holding roughly C$0.5 billion in net liquidity once the physical uranium position is marked to market. This fully covers Phoenix pre-production capex of ~C$400 million and eliminates near-term equity dilution risk. G&A run-rate of C$11.5 million in 2024 equates to less than 0.5% of NAV, evidence of a tightly managed cost base while the asset base is advanced.

  6. Relative Attraction
    On an enterprise-value-to-NAV basis Denison trades at 0.75×, a discount to both NexGen (1.15×) and IsoEnergy (0.85×) despite a far superior grade and lower projected cost. Closing the gap to peer median would place the shares above C$4.50; matching high-quality peer multiples points to the C$5.00 target and higher if uranium price momentum persists.

  7. Key Risk Matrix
    Permit delay is the most visible risk, mitigated by an already-approved provincial EA and a well-defined federal hearing schedule. ISR execution risk is mitigated by an 80% complete engineering package and a 2024 field demonstration that confirmed hydraulic connectivity and uranium recovery to design levels. Commodity downside is cushioned by a 70% operating margin at current prices. Financing risk is minimal given fully-funded capex.

  1. Bottom Line
    Denison offers a rare combination of verified high-grade reserves, an approved mining method, near-term regulatory catalysts and a cash-rich balance sheet. The arithmetic is straightforward: C$3.95 adjusted NAV × 1.25 quality multiple → C$5.00 target. Upcoming federal permitting and a rising uranium price provide two independent levers to drive the share price toward that level over the next twelve to eighteen months.


    FULL 15-PAGE QUANTITATIVE REPORT BELOW:

User's avatar

Continue reading this post for free, courtesy of SEQH Capital Research.

Or purchase a paid subscription.
© 2026 SEQH Capital Partners · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture